艾司利卡西平醋酸盐结构式
|
常用名 | 艾司利卡西平醋酸盐 | 英文名 | Eslicarbazepine acetate |
---|---|---|---|---|
CAS号 | 236395-14-5 | 分子量 | 296.320 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 427.4±55.0 °C at 760 mmHg | |
分子式 | C17H16N2O3 | 熔点 | 183-185ºC | |
MSDS | 中文版 美版 | 闪点 | 212.3±31.5 °C | |
符号 |
GHS07 |
信号词 | Warning |
艾司利卡西平醋酸盐用途Eslicarbazepine acetate 是一种抗癫痫药物,也是 β-内分泌酶 (β-Secretase) 和电压门控钠离子通道 (sodium channel) 的双抑制剂。 |
中文名 | 醋酸艾司利卡西平 |
---|---|
英文名 | eslicarbazepine acetate |
中文别名 | 艾司利卡西平醋酸盐 | 艾司利卡西平醋酸酯 | (S)-(-)-10-乙酸基-10,11-二氢-5H-二苯[b,f]吖庚因-5-甲酰胺 |
英文别名 | 更多 |
描述 | Eslicarbazepine acetate 是一种抗癫痫药物,也是 β-内分泌酶 (β-Secretase) 和电压门控钠离子通道 (sodium channel) 的双抑制剂。 |
---|---|
相关类别 | |
体内研究 | Eslicarbazepine acetate是一种抗癫痫药物。它是一种前药,被激活为eslicarbazepine(S-licarbazepine),一种奥卡西平的活性代谢产物。 Eslicarbazepine acetate是(S)-(+)- licarbazepine的前药,是奥卡西平的主要活性代谢产物。因此,其作用机制与奥卡西平相同。 Eslicarbazepine acetate可能不会立即产生高剂量的(S)-(+)- licarbazepine,奥卡西平也是如此,理论上可以改善耐受性[1]。 |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 427.4±55.0 °C at 760 mmHg |
熔点 | 183-185ºC |
分子式 | C17H16N2O3 |
分子量 | 296.320 |
闪点 | 212.3±31.5 °C |
精确质量 | 296.116089 |
PSA | 72.63000 |
LogP | 1.70 |
外观性状 | 固体;White to Almost white powder to crystal |
蒸汽压 | 0.0±1.0 mmHg at 25°C |
折射率 | 1.655 |
储存条件 | 0-10°C;避免加热 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xi: Irritant; |
风险声明 (欧洲) | 36/37/38 |
安全声明 (欧洲) | 26-36 |
危险品运输编码 | NONH for all modes of transport |
Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine.
Epilepsia 42 , 600-608, (2001) BIA 2-093 [(S)-(-)-10-acetoxy-10,11-dihydro-5H-dibenz/b,f/azepine-5-carboxamide] is endowed with an anticonvulsant potency similar to that of carbamazepine (CBZ), but produces less cognitive and motor... |
|
The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.
Neurochem. Int. 40 , 435-440, (2002) (S)-(-)-10-acetoxy-10,11-dihydro-5H-dibenz/b,f/azepine-5-carboxamide (BIA 2-093) is endowed with high anticonvulsant activity and shares with carbamazepine (CBZ) and oxcarbazepine (OXC) the capability... |
(10S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate |
5H-Dibenz[b,f]azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)- |
Exalief |
EslicarbazepineAcetate |
S-(−)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate |
(S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
Eslicarbazepine acetate |
Aptiom |
BIA 2-093 |
Zebinix |
UNII-BEA68ZVB2K |
Eslicarbazepine (acetate) |